Literature DB >> 10671226

Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1).

A Reich1, H Körner, J D Sedgwick, H Pircher.   

Abstract

TNF receptor-ligand interactions and CD95 (Fas / APO-1) have been demonstrated to be involved in activation-induced death of mature T cells. Here, we examined the role of these molecules in the murine model of lymphocytic choriomeningitis virus (LCMV) infection using LCMV TCR transgenic (tg) mice lacking TNF, TNF receptor I (TNFR1), CD95 or both TNFR1 and CD95. This report demonstrates that neither TNF receptor-ligand interactions nor CD95 was required for down-regulation of LCMV-specific CD8 T cells following acute LCMV infection in vivo. Even LCMV-specific CD8 T cells lacking both TNFR1 and CD95 molecules declined after the acute phase of the infection with normal kinetics. Furthermore, peripheral deletion of LCMV-specific CD8 T cells induced by LCMV peptide injection or by adoptive transfer of tg spleen cells expressing the corresponding LCMV epitope was not impaired in mice lacking TNF, TNFR1 and / or CD95. Our data speak against an indispensable role of these molecules in antigen-induced apoptosis of CD8 T cells in vivo and suggest that T cell homeostasis after antigen challenge is controlled by additional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671226     DOI: 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.

Authors:  Shenghua Zhou; Rong Ou; Lei Huang; Demetrius Moskophidis
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.

Authors:  Elena Sandalova; Cheng-Hong Wei; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

3.  Role of Bim in regulating CD8+ T-cell responses during chronic viral infection.

Authors:  Jason M Grayson; Ashley E Weant; Beth C Holbrook; David Hildeman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis.

Authors:  Sven Mostböck; Marta Catalfamo; Yutaka Tagaya; Jeffrey Schlom; Helen Sabzevari
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

5.  The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes.

Authors:  J Wan; D Martinvalet; X Ji; C Lois; S M Kaech; U H Von Andrian; J Lieberman; R Ahmed; N Manjunath
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

6.  Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Anju Singh; Christopher Fischer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 7.  Apoptosis and autophagy in the regulation of T lymphocyte function.

Authors:  Alexis Dunkle; You-Wen He
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

8.  Mutation in the Fas pathway impairs CD8+ T cell memory.

Authors:  Renu Dudani; Marsha Russell; Henk van Faassen; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

9.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10

10.  Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence.

Authors:  Christoph Wasem; Diana Arnold; Leslie Saurer; Nadia Corazza; Sabine Jakob; Simon Herren; Claudio Vallan; Christoph Mueller; Thomas Brunner
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.